Skip to main content

Table 2 Patient characteristics

From: Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial

 

Number

Percent

Parity

Nulliparous

18

35.3

Primiparous

19

37.3

Multiparous

14

27.4

Smoking

yes

14

27.5

no

37

72.5

Resumption of the menstrual cycle

yes

19

38.0

no

31

62.0

Chemotherapy regimen

A

18

35.3

T

30

58.5

AF

3

5.9

GnRH analog

yes

7

13.7

no

44

86.3

Tamoxifen

yes

32

62.7

no

19

37.3

  1. A anthracycline-based, AT combination with taxanes, AF anthracycline-free